Back to MW Marshall Wace, LLP

MRNAMRNA

Showing 5 of 24 quarters

Position history for MWMarshall Wace, LLP's holdings in Moderna, Inc.

Yes. Marshall Wace holds 163 shares of MRNA (Moderna), worth $11,718, as of its Q2 2026 13F filing. It reduced the position by 133,652 shares (-99.9%) from Q1 2026. Marshall Wace has held MRNA since Q3 2025, across 4 quarterly 13F filings.

Current Value

$11,718

Current Shares

163

Total Value Change

+$11,718

Total Shares Change

+163

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
163
-99.9%
$11,7180.0%$70.03
0
2026-Q1
Increased
133,815
+12.0%
$6.8M0.0%$50.80
31
2025-Q4
Decreased
119,441
-55.0%
$3.5M0.0%$29.49
0
2025-Q3
New
265,373
—
$6.9M0.0%$25.83
38
2024-Q3
Exited
0
-100.0%
$00.0%$65.75
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used